Tag Archives: First

Lilly’s Cyramza (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma

Print this page INDIANAPOLIS, May 13, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and… Read More »

First Edition: February 13, 2019

Today’s early morning highlights from the major news organizations. Kaiser Health News: Texans Can Appeal Surprise Medical Bills, But The Process Can Be Draining In Texas, a growing number of patients are turning to a little-known state mediation program to deal with unexpected hospital bills.The bills in question often arrive in patients’ mailboxes with shocking… Read More »

Shoveling out: only the first headache of 2019’s first winter storm – FOX61 Hartford

[unable to retrieve full-text content]Shoveling out: only the first headache of 2019’s first winter storm  FOX61 Hartford HARTFORD – People across the state woke up to snow and ended their Sunday with slush, rain, and ice. People were quickly hit with a mix of winter weather … "Dentistry|headache" – Google News